Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile,...

Published on 23 Jan 2025 on Benzinga · via Yahoo Finance

On Thursday, Vigil Neuroscience Inc. (NASDAQ:VIGL) released data from its completed Phase 1 trial...

Read the rest of the article

Start tracking your investments with Statfolio

On Thursday, Vigil Neuroscience Inc. (NASDAQ:VIGL) released data from its completed Phase 1 trial...

Benzinga · via Yahoo Finance 23 Jan 2025

Vigil Neuroscience Inc. (NASDAQ:VIGL) released interim data on Wednesday from its ongoing Phase 1...

Benzinga · via Yahoo Finance 22 Jul 2024

Penny stocks have a unique appeal– one that only strong-stomached, risky-taking investors find...

InvestorPlace · via Yahoo Finance 21 Jun 2024

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 21 Jun 2024

Vigil Neuroscience (VIGL) might move higher on growing optimism about its earnings prospects, whi...

Zacks · via Yahoo Finance 21 May 2024

The most talked about and market moving research calls around Wall Street are now in one place. H...

The Fly via Yahoo Finance 18 Oct 2023

Vigil Neuroscience Inc (NASDAQ: VIGL) announced interim topline results from its ongoing Phase 1 ...

Benzinga via Yahoo Finance 2 Nov 2022

Vigil Neuroscience, Inc. (VIGL) closed the last trading session at $8.38, gaining 26% over the pa...

Zacks via Yahoo Finance 29 Aug 2022

Vigil Neuroscience, Inc. (VIGL) closed the last trading session at $7.31, gaining 62.4% over the ...

Zacks via Yahoo Finance 12 Aug 2022